Revvity SEC filings, summarized
We read every Revvity 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.
Track RVTY in your inbox
Add Revvity to your watchlist — free, every morning.
Recent filings
Revvity furnishes press release (Ex.99.1) dated Feb 2, 2026 announcing financial results for Q4 and full…
Revvity furnishes press release (Ex.99.1) dated Feb 2, 2026 announcing financial results for Q4 and full year 2025 — see release for revenue, EPS and…
Revvity ($RVTY) announced Q4 and FY results for the period ended Dec 28, 2025; press release furnished as…
Revvity ($RVTY) announced Q4 and FY results for the period ended Dec 28, 2025; press release furnished as Exhibit 99.1. Announcement date: Feb 2, 2026.…
Revvity ($RVTY) to hold an earnings call Monday, Feb 2, 2026 — press release issued Jan 12, 2026 (Exhibit…
Revvity ($RVTY) to hold an earnings call Monday, Feb 2, 2026 — press release issued Jan 12, 2026 (Exhibit 99.1, furnished not filed). Key date for FY/Q4…
REVVITY CEO Dr.
REVVITY CEO Dr. Prahlad Singh will present at the 44th Annual J.P. Morgan Healthcare Conference on Jan 13, 2026; presentation materials furnished as Exhibit…
Revvity ($RVTY) announced preliminary expectations for Q4 (ended Dec 28, 2025) on Jan 12, 2026 and will…
Revvity ($RVTY) announced preliminary expectations for Q4 (ended Dec 28, 2025) on Jan 12, 2026 and will release its Q4 & FY2025 results on Feb 2, 2026.…